Relationship with investors

Forallbio Inc., pays great attention to the management of the relationship between the company and shareholders, creditors and potential investors, including the relationship management between the company and various intermediaries in the capital market during the communication with investors
The company entrusts professional institutions to use the principles of financial communication and marketing to manage the content and channels of information communication between the company and the financial and other sectors, to maximize the value of relevant stakeholders and to obtain widespread approval from investors as scheduled, and to regulate the operation of the capital market , To achieve external incentives on the company’s operating constraints, to maximize shareholder value and protect the interests of investors, and to ease the pressure of regulators, etc.

Corporate governance

Corporate or institutional governance refers to the leadership, management, and accountability procedures and related organizational structure of an enterprise or organization. In the case of an enterprise, this involves the interrelationships between the company’s management, the board of directors, shareholders and other stakeholders.
The term corporate governance has many meanings. It may describe:

1. Company command and control process
2. Strict adherence to company rules (such as rules set out in the Corporate Governance Guide)
3. Owned investment technology and corporate governance funds
4. Problems separating ownership and control
5. Forallbio Inc., will set up an experienced team to handle corporate and institutional governance

Frequently asked questions

問

答

In which country is Forallbio Inc., registered?
Forallbio Inc., has established an offshore holding structure in the Cayman Islands, a global operations headquarters in Hong Kong, and also established offices in Taiwan, China, Malaysia and Vietnam.
Which is the independent audit firm of Forallbio Inc., ?

Forallbio Inc. has hired an audit firm with 30 years of experience in Taiwan to handle domestic and foreign accounting matters. Hong Kong companies will also hire international accounting firms.

What is the development layout of Forallbio Inc., ?

Forallbio’s products have been taken in more than 20 countries and it is expected to expand to 30 by the end of 2020. In terms of developing genetic protein tests, Fuzhong Biomedical expects to cooperate with Chinese and Asian hospitals by the end of 2020 to reach 1,000 tests per year.

What is the research and development strength of Forallbio Inc., ? What are the main R & D directions?

Looking forward to the new decade of 2020, Forallbio Inc., will continue to focus on the research of cancer and telomere structure, and launch patented blood tests for more accurate and popular multi-molecular protein therapy assessment and monitoring. In terms of anti-aging and anti-cancer, Fuzhong Biomedicine will develop more personalized and routine health care methods to keep many people away from illness.

What are the current strategic partners of Forallbio Inc., ?

Forallbio Inc., is currently about to establish strategic partnerships in many countries in Europe and Asia, including Germany, Switzerland, China, Japan, Malaysia and Vietnam. The key goal is to find and combine more high-quality and scientific treatment methods to establish a one-stop health care coverage system.

When will Forallbio Inc., conduct the next round of financing?

Stepping into 2020, Forallbio Prospects will show international investors the most sustainable side. In addition to applying for membership of the United Nations Compact Enterprise, Fuzhong Biomedical will continue to expand overseas cooperation. The financing plan is expected to be completed by the first quarter of 2020.

FAQ 常見問題

In which country is Forallbio Inc., registered?
Forallbio Inc., has established an offshore holding structure in the Cayman Islands, a global operations headquarters in Hong Kong, and also established offices in Taiwan, China, Malaysia and Vietnam.
Which is the independent audit firm of Forallbio Inc., ?
Forallbio Inc. has hired an audit firm with 30 years of experience in Taiwan to handle domestic and foreign accounting matters. Hong Kong companies will also hire international accounting firms.
What is the development layout of Forallbio Inc., ?
Forallbio’s products have been taken in more than 20 countries and it is expected to expand to 30 by the end of 2020. In terms of developing genetic protein tests, Fuzhong Biomedical expects to cooperate with Chinese and Asian hospitals by the end of 2020 to reach 1,000 tests per year.
What is the research and development strength of Forallbio Inc., ? What are the main R & D directions?
Looking forward to the new decade of 2020, Forallbio Inc., will continue to focus on the research of cancer and telomere structure, and launch patented blood tests for more accurate and popular multi-molecular protein therapy assessment and monitoring. In terms of anti-aging and anti-cancer, Fuzhong Biomedicine will develop more personalized and routine health care methods to keep many people away from illness.
What are the current strategic partners of Forallbio Inc., ?
Forallbio Inc., is currently about to establish strategic partnerships in many countries in Europe and Asia, including Germany, Switzerland, China, Japan, Malaysia and Vietnam. The key goal is to find and combine more high-quality and scientific treatment methods to establish a one-stop health care coverage system.
When will Forallbio Inc., conduct the next round of financing?
Stepping into 2020, Forallbio Prospects will show international investors the most sustainable side. In addition to applying for membership of the United Nations Compact Enterprise, Fuzhong Biomedical will continue to expand overseas cooperation. The financing plan is expected to be completed by the first quarter of 2020.